Redcare Pharmacy NV

RDC

NL0012044747

Drug Retailers

Market Closed - Xetra Other stock markets 11:35:20 2024-04-26 am EDT			5-day change	1st Jan Change
130 ^EUR	0.00%		+0.78%	-1.22%

Apr. 26	REDCARE PHARMACY : Deutsche Bank reiterates its Buy rating	ZD
Apr. 26	REDCARE PHARMACY : Hauck & Aufhauser keeps its Buy rating	ZD

REDCARE PHARMACY : Warburg Research remains Neutral

March 06, 2024 at 04:16 am EST

Analyst Michael Heider from Warburg Research research gives the stock a Neutral rating. The target price has been lifted and is now set at EUR 138 compared to EUR 130 before.

Latest news about Redcare Pharmacy NV

REDCARE PHARMACY : Deutsche Bank reiterates its Buy rating	Apr. 26	ZD
REDCARE PHARMACY : Hauck & Aufhauser keeps its Buy rating	Apr. 26	ZD
REDCARE PHARMACY : Receives a Buy rating from Baader Bank	Apr. 25	ZD
REDCARE PHARMACY : Warburg Research reaffirms its Neutral rating	Apr. 25	ZD
REDCARE PHARMACY : Jefferies maintains a Buy rating	Apr. 25	ZD
Redcare Pharmacy NV Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 25	CI
Transcript : Redcare Pharmacy NV, Q1 2024 Earnings Call, Apr 25, 2024	Apr. 24
REDCARE PHARMACY : Receives a Buy rating from Baader Bank	Apr. 24	ZD
Swiss online drug delivery firm DocMorris reports slight miss in Q1 sales	Apr. 16	RE
REDCARE PHARMACY : Gets a Buy rating from Jefferies	Apr. 12	ZD
REDCARE PHARMACY : Warburg Research remains Neutral	Apr. 05	ZD
REDCARE PHARMACY : Deutsche Bank maintains a Buy rating	Apr. 05	ZD
REDCARE PHARMACY : Warburg Research gives a Neutral rating	Apr. 04	ZD
REDCARE PHARMACY : Baader Bank maintains a Buy rating	Apr. 04	ZD
REDCARE PHARMACY : Hauck & Aufhauser keeps its Buy rating	Apr. 04	ZD
REDCARE PHARMACY : Jefferies reaffirms its Buy rating	Apr. 04	ZD
REDCARE PHARMACY : Deutsche Bank reiterates its Buy rating	Mar. 22	ZD
REDCARE PHARMACY : Buy rating from Hauck & Aufhauser	Mar. 15	ZD
REDCARE PHARMACY : Warburg Research reaffirms its Neutral rating	Mar. 15	ZD
REDCARE PHARMACY : Jefferies reaffirms its Buy rating	Mar. 14	ZD
REDCARE PHARMACY : Hauck & Aufhauser reiterates its Buy rating	Mar. 12	ZD
REDCARE PHARMACY : Berenberg maintains a Buy rating	Mar. 12	ZD
REDCARE PHARMACY : Deutsche Bank reiterates its Buy rating	Mar. 11	ZD
REDCARE PHARMACY : Deutsche Bank reaffirms its Buy rating	Mar. 06	ZD
REDCARE PHARMACY : Hauck & Aufhauser reiterates its Buy rating	Mar. 06	ZD

Redcare Pharmacy NV is a company based in the Netherlands that retails pharmaceutical products online. The Company focuses on non-prescription medication (OTC), as well as on pharmacy-related beauty and personal care (BPC) products. The Company is active in Belgium, Spain, Italy, France, Austria, the Netherlands and Germany.

Sector

Drug Retailers

Calendar

2024-07-29 - Q2 2024 Earnings Release

Related indices

MDAX

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

Shop Apotheke Europe N.V. : Growth still not profitable

March 09, 2023 at 11:32 am EST

More Strategies

Ratings for Redcare Pharmacy NV

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

130 EUR

Average target price

155.2 EUR

Spread / Average Target

+19.37%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Drug Retailers

	1st Jan change	Capi.
REDCARE PHARMACY NV	-1.22%	2.8B
WALGREENS BOOTS ALLIANCE, INC.	-32.21%	15.27B
JD HEALTH INTERNATIONAL INC.	-31.97%	10.84B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-30.42%	6.06B
YIFENG PHARMACY CHAIN CO., LTD.	+8.14%	6.04B
MATSUKIYOCOCOKARA & CO.	-11.41%	5.86B
NAHDI MEDICAL COMPANY	-0.88%	4.71B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+52.19%	4.29B
CLICKS GROUP LIMITED	-12.31%	3.61B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	-14.86%	3.33B

Other Drug Retailers

Redcare Pharmacy NV

Equities

RDC

NL0012044747

Drug Retailers

REDCARE PHARMACY : Warburg Research remains Neutral

Latest news about Redcare Pharmacy NV

Chart Redcare Pharmacy NV

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for Redcare Pharmacy NV

Analysts' Consensus

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Other Drug Retailers